# Amphotericin B liposome

NDC: 67457-926
Generic name: Amphotericin B liposome
Labeler / Manufacturer: Mylan Institutional LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Routes: INTRAVENOUS
Marketing started: 20250806

FDA application: ANDA212967

## Active ingredients

- AMPHOTERICIN B: 50 mg/12.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67457-926"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67457-926
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a96a734f-d1c4-4d42-93c2-7c336da7f7b9